These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
748 related articles for article (PubMed ID: 17552924)
1. Oncoproteomics: current trends and future perspectives. Cho WC; Cheng CH Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924 [TBL] [Abstract][Full Text] [Related]
2. Role of oncoproteomics in the personalized management of cancer. Jain KK Expert Rev Proteomics; 2004 Jun; 1(1):49-55. PubMed ID: 15966798 [TBL] [Abstract][Full Text] [Related]
3. The molecular make-up of a tumour: proteomics in cancer research. Kolch W; Mischak H; Pitt AR Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087 [TBL] [Abstract][Full Text] [Related]
7. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways. Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530 [TBL] [Abstract][Full Text] [Related]
8. Proteomic approaches for serum biomarker discovery in cancer. Maurya P; Meleady P; Dowling P; Clynes M Anticancer Res; 2007; 27(3A):1247-55. PubMed ID: 17593616 [TBL] [Abstract][Full Text] [Related]
9. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy. Calvo KR; Liotta LA; Petricoin EF Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423 [TBL] [Abstract][Full Text] [Related]
10. Cancer proteomics: Serum diagnostics for tumor marker discovery. Rai AJ; Chan DW Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974 [TBL] [Abstract][Full Text] [Related]
11. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics. Bharti A; Ma PC; Salgia R Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130 [TBL] [Abstract][Full Text] [Related]
13. Advanced proteomic technologies for cancer biomarker discovery. Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940 [TBL] [Abstract][Full Text] [Related]
14. Protein microarrays for cancer diagnostics and therapy. Lin JC Med Princ Pract; 2010; 19(4):247-54. PubMed ID: 20516699 [TBL] [Abstract][Full Text] [Related]
15. Proteomics and the haematologist. Rees-Unwin KS; Morgan GJ; Davies FE Clin Lab Haematol; 2004 Apr; 26(2):77-86. PubMed ID: 15053800 [TBL] [Abstract][Full Text] [Related]
17. Clinical proteomics in breast cancer: a review. Gast MC; Schellens JH; Beijnen JH Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706 [TBL] [Abstract][Full Text] [Related]
18. Integrative oncoproteomics strategies for anticancer drug discovery. Liu R; Wang K; Yuan K; Wei Y; Huang C Expert Rev Proteomics; 2010 Jun; 7(3):411-29. PubMed ID: 20536311 [TBL] [Abstract][Full Text] [Related]
19. Current trends in computational inference from mass spectrometry-based proteomics. Webb-Robertson BJ; Cannon WR Brief Bioinform; 2007 Sep; 8(5):304-17. PubMed ID: 17584764 [TBL] [Abstract][Full Text] [Related]
20. Proteomics-driven cancer biomarker discovery: looking to the future. Simpson RJ; Bernhard OK; Greening DW; Moritz RL Curr Opin Chem Biol; 2008 Feb; 12(1):72-7. PubMed ID: 18295612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]